Helio Genomics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 67

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $35M

  • Investors
  • 2

Helio Genomics General Information

Description

Provider of cancer diagnosis and testing services intended to simplify cancer screening to save lives by detecting the disease at an early stage. The company uses artificial intelligence and machine learning algorithms along with non-invasive, non-toxic technologies to identify unique and proprietary DNA signatures that predict the presence of cancer as early as stage one, enabling patients to detect the onset of cancer from a single blood draw.

Contact Information

Website
www.heliogenomics.com
Formerly Known As
Helio Health
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 9950 Research Drive
  • Irvine, CA 92618
  • United States
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Healthcare Services
Vertical(s)
Artificial Intelligence & Machine Learning, Life Sciences, Oncology
Corporate Office
  • 9950 Research Drive
  • Irvine, CA 92618
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Helio Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series B) 09-Aug-2021 $35M Completed Generating Revenue/Not Profitable
2. Later Stage VC 04-Nov-2019 Completed Generating Revenue
1. Early Stage VC (Series A) 03-Jan-2017 $30M $30M Completed Startup
To view Helio Genomics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Helio Genomics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of cancer diagnosis and testing services intended to simplify cancer screening to save lives by detecting the d
Laboratory Services (Healthcare)
Irvine, CA
67 As of 2025

Brisbane, CA
 

Baltimore, MD
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Helio Genomics Competitors (3)

One of Helio Genomics’s 3 competitors is Freenome, a Venture Capital-Backed company based in Brisbane, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Freenome Venture Capital-Backed Brisbane, CA
Delfi Diagnostics Venture Capital-Backed Baltimore, MD
Exact Sciences Formerly VC-backed Madison, WI
You’re viewing 3 of 3 competitors. Get the full list »

Helio Genomics Patents

  • 27

    Total Documents Applications and Grants

  • Total Patents Families

  • 14

    Granted

  • 11

    Pending

  • Expiring in next 12 mo

Helio Genomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023228901-A1 Methods for multimodal epigenetic sequencing assays Pending 03-Mar-2022
EP-4486923-A2 Methods for multimodal epigenetic sequencing assays Pending 03-Mar-2022
US-20230323473-A1 Methods for multimodal epigenetic sequencing assays Pending 03-Mar-2022
US-20240194295-A1 Cellular heterogeneity-adjusted clonal methylation (chalm): a methylation quantification method Pending 21-Apr-2021
US-20240209453-A1 Liver cancer methylation and protein markers and their uses Pending 21-Apr-2021 C12Q1/6886
To view Helio Genomics’s complete patent history, request access »

Helio Genomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Helio Genomics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Fulgent Genetics Corporation Minority
Samsung Securities Corporation Minority
To view Helio Genomics’s complete investors history, request access »

Ready to get started?

Request a free trial

Helio Genomics FAQs

  • When was Helio Genomics founded?

    Helio Genomics was founded in 2015.

  • Where is Helio Genomics headquartered?

    Helio Genomics is headquartered in Irvine, CA.

  • What is the size of Helio Genomics?

    Helio Genomics has 67 total employees.

  • What industry is Helio Genomics in?

    Helio Genomics’s primary industry is Laboratory Services (Healthcare).

  • Is Helio Genomics a private or public company?

    Helio Genomics is a Private company.

  • What is Helio Genomics’s current revenue?

    The current revenue for Helio Genomics is .

  • How much funding has Helio Genomics raised over time?

    Helio Genomics has raised $108M.

  • Who are Helio Genomics’s investors?

    Fulgent Genetics and Samsung Securities have invested in Helio Genomics.

  • Who are Helio Genomics’s competitors?

    Freenome, Delfi Diagnostics, and Exact Sciences are competitors of Helio Genomics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »